Amylyx Archives -

Amylyx Pharmaceuticals’ efforts to bring its amyotrophic lateral sclerosis therapy AMX0035 to market in the US have run

Amylyx bags first approval for ALS drug Albrioza

https://pharmaphorum.com/news/amylyx-bags-first-approval-for-als-drug-albrioza/

By a narrow margin, an FDA advisory committee has voted against approval of Amylyx’ experimental medicine for amyotrophic

Patients dismayed as FDA advisors narrowly reject Amylyx’ ALS drug

https://pharmaphorum.com/news/patients-dismayed-as-fda-advisors-narrowly-reject-amylyx-als-drug/

Shares in Amylyx Pharma slid today after the FDA published a less-than-enthusiastic assessment of its amyotrophic lateral sclerosis

Amylyx slumps on non-committal FDA reviewer assessment of ALS drug

https://pharmaphorum.com/news/amylyx-slumps-on-non-committal-fda-reviewer-assessment-of-als-drug/

Just a few months ago, Amylyx was talking about having to complete another clinical trial before it could

Amylyx preps filing for its ALS drug after FDA feedback

https://pharmaphorum.com/news/amylyx-preps-filing-for-its-als-drug-after-fda-feedback/

Amylyx